Skip to content

Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)

Modifications in the Anaerob Threshold in Cyclists (DHA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04128449
Acronym
MATCY
Enrollment
38
Registered
2019-10-16
Start date
2018-04-01
Completion date
2018-06-30
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Performance

Keywords

performance, cyclists, docosahexaenoic acid, anaerobic threshold

Brief summary

In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.

Interventions

DIETARY_SUPPLEMENTdocosahexaenoic acid

5 dragees every 24 hours

DIETARY_SUPPLEMENTPlacebo

5 dragees every 24 hours

Sponsors

Universidad Católica San Antonio de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Male between 18 and 75 years old. * Cyclists who train three or four times a week.

Exclusion criteria

* Suffering some type of chronic disease. * Consume habitually pharmacological treatments that could influence the physiological or biochemical responses to be analyzed in the present work. * Consumption in the month prior to the start of the study, or during the performance of the same, functional food enriched with omega-3 fatty acids. * To present during the performance of the stress tests, any of the absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1999) 15 would be duly informed and excluded from the present study.

Design outcomes

Primary

MeasureTime frameDescription
ergospirometry variable: heart rateThe change was evaluated after one month of product consumption.It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Heart rate was measured in beats per minute.
ergospirometry variable: absolute oxygen consumptionThe change was evaluated after one month of consumption of the productIt was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym).It was measured in milliliters per minute

Secondary

MeasureTime frameDescription
ergospirometry variable:respiratory ratioThe change was evaluated after one month of consumption of the productIt was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Through the oxycon pro jaeger gas analyzer.
ergospirometry variable: oxygen equivalentThe change was evaluated after one month of consumption of the productIt was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Through the oxycon pro jaeger gas analyzer.
blood variables: Natremia, potassium, chloremia, calcemia, , bicarbononatemia, ph, lactacidemia.The change was evaluated after one month of product consumption.The following variables were analyzed: The variables are analyzed using the ABL 77 radiometer. The unit of measurement is mmol / L.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026